| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1084513328 |
| P356 | DOI | 10.1007/S00467-017-3641-4 |
| P698 | PubMed publication ID | 28378029 |
| P2093 | author name string | Tomoyuki Sakai | |
| Takashi Ando | |||
| Hiroshi Hataya | |||
| Kentaro Ogata | |||
| Riku Hamada | |||
| Kenji Ishikura | |||
| Masataka Honda | |||
| Yuko Hamasaki | |||
| Fumiyo Komaki | |||
| P2860 | cites work | Non-corticosteroid treatment for nephrotic syndrome in children | Q24242865 |
| Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations | Q33300551 | ||
| Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome | Q36153584 | ||
| Two-year follow-up of a prospective clinical trial of cyclosporine for frequently relapsing nephrotic syndrome in children | Q36294318 | ||
| Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome | Q37202763 | ||
| Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome | Q37330330 | ||
| Cyclosporine C2 monitoring for the treatment of frequently relapsing nephrotic syndrome in children: a multicenter randomized phase II trial | Q37553134 | ||
| Rituximab treatment for relapsing minimal change disease and focal segmental glomerulosclerosis: a systematic review. | Q38206050 | ||
| Revised equations for estimated GFR from serum creatinine in Japan | Q39513402 | ||
| Immunosuppressive therapy in children with steroid-resistant, frequently-relapsing, and steroid-dependent idiopathic nephrotic syndrome: a single center experience | Q39881156 | ||
| Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
| Treatment with microemulsified cyclosporine in children with frequently relapsing nephrotic syndrome | Q43041744 | ||
| Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome | Q43461510 | ||
| Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions | Q43604565 | ||
| Effectiveness of a second course of cyclophosphamide therapy in children with frequently relapsing nephrotic syndrome after cyclosporin A therapy. | Q43630581 | ||
| Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome | Q44458286 | ||
| Single-dose daily administration of cyclosporin A for relapsing nephrotic syndrome | Q44908298 | ||
| Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease | Q45174517 | ||
| Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome | Q46486654 | ||
| Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome | Q46609105 | ||
| Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience | Q46705142 | ||
| Is single-daily low-dose cyclosporine therapy really effective in children with idiopathic frequent-relapsing nephrotic syndrome? | Q46792683 | ||
| Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. | Q50664664 | ||
| Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy. | Q53625850 | ||
| Early identification of frequent relapsers among children with minimal change nephrotic syndrome. A report of the International Study of Kidney Disease in Children | Q70455737 | ||
| Long-term clinical and pathological effects of cyclosporin in children with nephrosis | Q73639741 | ||
| Recovery from cyclosporine-associated arteriolopathy in childhood nephrotic syndrome | Q74396105 | ||
| Two-year cyclosporin treatment in children with steroid-dependent nephrotic syndrome | Q74663185 | ||
| Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome | Q80248543 | ||
| Effective and safe treatment with cyclosporine in nephrotic children: a prospective, randomized multicenter trial | Q80786696 | ||
| Effect of single-dose oral mizoribine pulse therapy twice per week for frequently relapsing steroid-dependent nephrotic syndrome | Q84456168 | ||
| Positive role of rituximab in switching from cyclosporine to mycophenolate mofetil for children with high-dose steroid-dependent nephrotic syndrome | Q86504669 | ||
| Uncertainty in management of childhood-onset idiopathic nephrotic syndrome: is the long-term prognosis really favorable? | Q87054758 | ||
| P433 | issue | 8 | |
| P921 | main subject | cyclosporine | Q367700 |
| nephrotic syndrome | Q504790 | ||
| P304 | page(s) | 1383-1390 | |
| P577 | publication date | 2017-04-04 | |
| P1433 | published in | Pediatric Nephrology | Q15749796 |
| P1476 | title | Nephrotoxicity in children with frequently relapsing nephrotic syndrome receiving long-term cyclosporine treatment | |
| P478 | volume | 32 |
| Q89838674 | Current understandings in treating children with steroid-resistant nephrotic syndrome |
| Q88205486 | Impact of interrupted cyclosporine treatment on the development of chronic nephrotoxicity in children with steroid-dependent nephrotic syndrome |
| Q90084496 | Infrequent tacrolimus-induced nephrotoxicity in French patients with steroid-dependent nephrotic syndrome |
Search more.